Sodium Intake, ACE Inhibition, and Progression to ESRD
Vegter S, Perna A, Postma MJ, Navis G, Remuzzi G, Ruggenenti P. J Am Soc Nephrol. 2012 Jan;23(1):165-73
The impact of sodium intake on clinical outcomes has recently come under some scrutiny and the topic is surrounded by debate. In this retrospective analysis of the REIN study, patients with non-diabetic CKD who had high dietary salt (>14 g daily) had a blunted antiproteinuric effect from ACE inhibitor therapy and increase the risk for ESRD, independent of BP control.
Related Articles:
- Strict Blood-Pressure Control and Progression of Renal Failure in Children
- Effective population-wide public health interventions to promote sodium reduction
- Persistent Asymptomatic Isolated Microscopic Hematuria in Israeli Adolescents and Young Adults and Risk for End-Stage Renal Disease
Recent Comments